Quick Custom Intelligence and Maropost Power Real-Time Data at Enterprise Scale
SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI)…
SoftBank Corp. Evolves Telecom Infrastructure for the AI Era: From Carrying Data to Orchestrating Intelligence
SoftBank is transitioning from a traditional telecommunications carrier into an AI infrastructure provider, orchestrating intelligence across…
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as…
Huawei Launches AI Data Platform to Bridge Models and Business Value
BARCELONA, Spain, March 5, 2026 /PRNewswire/ -- At the Huawei Product &…
Huawei Launches Its AI Data Platform to Power Faster AI Adoption for Enterprises
BARCELONA, Spain, March 4, 2026 /PRNewswire/ -- At the Huawei AI DC…
Union Minister for Communications launches Tejas Networks’ hyper-scalable Data Center Interconnect (DCI) platform at Mobile World Congress
BENGALURU, India and BARCELONA, Spain, March 4, 2026 /PRNewswire/ -- Tejas Networks…
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142)…
Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and Best-in-Disease
March 01, 2026 09:45 ET | Source: Celldex Therapeutics, Inc. - Late…
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful…
Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
February 28, 2026 09:45 ET | Source: Cogent Biosciences, Inc. Bezuclastinib mean…
